Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Open Forum Infect Dis ; 11(4): ofae170, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38585186

ABSTRACT

The acute retroviral syndrome may present with diverse systemic manifestations and laboratory abnormalities. Here we present a rare case of primary human immunodeficiency virus (HIV) infection causing severe acute hepatitis. Liver histopathology demonstrated a pattern of lymphocytic inflammation consistent with acute hepatitis, high levels of HIV proviral DNA were detected within liver tissue, and immunofluorescence showed HIV p24 antigen within immune and parenchymal cells including hepatocytes. We review the literature pertaining to HIV infection of cell compartments within the liver and discuss the implications for HIV-associated acute liver disease.

2.
BMJ Case Rep ; 15(3)2022 Mar 01.
Article in English | MEDLINE | ID: mdl-35232746

ABSTRACT

A man fully mRNA-vaccinated against COVID-19 presented to our hospital with an acute febrile illness, respiratory symptoms and a positive test for SARS-CoV-2. He was later found early into hospitalisation to have two morbid bacterial co-infections: Legionella pneumophila serogroup 1 and methicillin-resistant Staphylococcus aureus (MRSA). Although this patient was initially admitted for COVID-19 management, his initial presentation was remarkable for lobar pneumonia, hyponatraemia and rhabdomyolysis more compatible with Legionnaire's disease than severe COVID-19. On discovery of MRSA pneumonia as a second bacterial infection, immunosuppressive COVID-19 therapies were discontinued and targeted antibiotics towards both bacterial co-infections were initiated. The patient's successful recovery highlighted the need to have high suspicion for bacterial co-infections in patients presenting with community-acquired pneumonia and a positive SARS-CoV-2 test, as patients with serious bacterial co-infections may have worse outcomes with use of immunosuppressive COVID-19 therapies.


Subject(s)
COVID-19 , Coinfection , Community-Acquired Infections , Legionella pneumophila , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections , Anti-Bacterial Agents/therapeutic use , COVID-19/complications , Coinfection/diagnosis , Community-Acquired Infections/microbiology , Humans , Male , SARS-CoV-2 , Staphylococcal Infections/complications , Staphylococcal Infections/diagnosis , Staphylococcal Infections/drug therapy , Staphylococcus aureus
3.
J Immunol ; 200(9): 3047-3052, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29602772

ABSTRACT

The NLRP3 inflammasome is activated in response to microbial and danger signals, resulting in caspase-1-dependent secretion of the proinflammatory cytokines IL-1ß and IL-18. Canonical NLRP3 inflammasome activation is a two-step process requiring both priming and activation signals. During inflammasome activation, NLRP3 associates with mitochondria; however, the role for this interaction is unclear. In this article, we show that mouse NLRP3 and caspase-1 independently interact with the mitochondrial lipid cardiolipin, which is externalized to the outer mitochondrial membrane at priming in response to reactive oxygen species. An NLRP3 activation signal is then required for the calcium-dependent association of the adaptor molecule ASC with NLRP3 on the mitochondrial surface, resulting in inflammasome complex assembly and activation. These findings demonstrate a novel lipid interaction for caspase-1 and identify a role for mitochondria as supramolecular organizing centers in the assembly and activation of the NLRP3 inflammasome.


Subject(s)
Cardiolipins/metabolism , Caspase 1/metabolism , Inflammasomes/metabolism , Mitochondria/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Animals , Cardiolipins/immunology , Caspase 1/immunology , Inflammasomes/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitochondria/immunology , NLR Family, Pyrin Domain-Containing 3 Protein/immunology
4.
Nat Commun ; 7: 13180, 2016 10 25.
Article in English | MEDLINE | ID: mdl-27779193

ABSTRACT

The inbred mouse strain C57BL/6J is widely used in models of immunological and infectious diseases. Here we show that C57BL/6J mice have a defect in neutrophil recruitment to a range of inflammatory stimuli compared with the related C57BL/6N substrain. This immune perturbation is associated with a missense mutation in Nlrp12 in C57BL/6J mice. Both C57BL/6J and NLRP12-deficient mice have increased susceptibility to bacterial infection that correlates with defective neutrophil migration. C57BL/6J and NLRP12-deficient macrophages have impaired CXCL1 production and the neutrophil defect observed in C57BL/6J and NLRP12-deficient mice is rescued by restoration of macrophage NLRP12. These results demonstrate that C57BL/6J mice have a functional defect in NLRP12 and that macrophages require NLRP12 expression for effective recruitment of neutrophils to inflammatory sites.


Subject(s)
Chemokine CXCL1/genetics , Intracellular Signaling Peptides and Proteins/genetics , Macrophages/pathology , Mutation , Neutrophils/pathology , Tularemia/immunology , Animals , Base Sequence , Cell Movement , Chemokine CXCL1/deficiency , Chemokine CXCL1/immunology , Disease Susceptibility , Francisella tularensis/immunology , Gene Expression , Immunity, Innate , Intracellular Signaling Peptides and Proteins/deficiency , Intracellular Signaling Peptides and Proteins/immunology , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Macrophages/immunology , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Neutrophils/drug effects , Neutrophils/immunology , Survival Analysis , Tularemia/genetics , Tularemia/microbiology , Tularemia/mortality
5.
Immunity ; 44(4): 713-5, 2016 Apr 19.
Article in English | MEDLINE | ID: mdl-27096310

ABSTRACT

Generally, two signals are required to activate the NLRP3 inflammasome. In this issue of Immunity, Hornung and colleagues (2016) describe an alternative inflammasome activation pathway in human monocytes triggering activation of the NLRP3 inflammasome in response to a single stimulus.


Subject(s)
Caspase 1/metabolism , Monocytes/metabolism , Carrier Proteins/metabolism , Humans , Inflammasomes/metabolism , Interleukin-1beta/metabolism , Reactive Oxygen Species/metabolism
6.
Immunol Rev ; 265(1): 35-52, 2015 May.
Article in English | MEDLINE | ID: mdl-25879282

ABSTRACT

The NLRP3 (NOD-like receptor family, pyrin domain containing 3) inflammasome is a multiprotein complex that orchestrates innate immune responses to infection and cell stress through activation of caspase-1 and maturation of inflammatory cytokines pro-interleukin-1ß (pro-IL-1ß) and pro-IL-18. Activation of the inflammasome during infection can be protective, but unregulated NLRP3 inflammasome activation in response to non-pathogenic endogenous or exogenous stimuli can lead to unintended pathology. NLRP3 associates with mitochondria and mitochondrial molecules, and activation of the NLRP3 inflammasome in response to diverse stimuli requires cation flux, mitochondrial Ca(2+) uptake, and mitochondrial reactive oxygen species accumulation. It remains uncertain whether NLRP3 surveys mitochondrial integrity and senses mitochondrial damage, or whether mitochondria simply serve as a physical platform for inflammasome assembly. The structure of the active, caspase-1-processing NLRP3 inflammasome also requires further clarification, but recent studies describing the prion-like properties of ASC have advanced the understanding of how inflammasome assembly and caspase-1 activation occur while raising new questions regarding the propagation and resolution of NLRP3 inflammasome activation. Here, we review the mechanisms and pathways regulating NLRP3 inflammasome activation, discuss emerging concepts in NLRP3 complex organization, and expose the knowledge gaps hindering a comprehensive understanding of NLRP3 activation.


Subject(s)
Carrier Proteins/metabolism , Inflammasomes/metabolism , Mitochondria/metabolism , Multiprotein Complexes/metabolism , Animals , Calcium Signaling , Carrier Proteins/immunology , Caspase 1/metabolism , Humans , Immunity, Innate , Inflammasomes/immunology , Multiprotein Complexes/immunology , NLR Family, Pyrin Domain-Containing 3 Protein
7.
Immunity ; 39(2): 311-323, 2013 Aug 22.
Article in English | MEDLINE | ID: mdl-23954133

ABSTRACT

Nlrp3 inflammasome activation occurs in response to numerous agonists but the specific mechanism by which this takes place remains unclear. All previously evaluated activators of the Nlrp3 inflammasome induce the generation of mitochondrial reactive oxygen species (ROS), suggesting a model in which ROS is a required upstream mediator of Nlrp3 inflammasome activation. Here we have identified the oxazolidinone antibiotic linezolid as a Nlrp3 agonist that activates the Nlrp3 inflammasome independently of ROS. The pathways for ROS-dependent and ROS-independent Nlrp3 activation converged upon mitochondrial dysfunction and specifically the mitochondrial lipid cardiolipin. Cardiolipin bound to Nlrp3 directly and interference with cardiolipin synthesis specifically inhibited Nlrp3 inflammasome activation. Together these data suggest that mitochondria play a critical role in the activation of the Nlrp3 inflammasome through the direct binding of Nlrp3 to cardiolipin.


Subject(s)
Cardiolipins/metabolism , Carrier Proteins/metabolism , Inflammasomes/metabolism , Mitochondria/metabolism , Acetamides/metabolism , Acetamides/pharmacology , Animals , Cardiolipins/immunology , Cell Line , Cyclosporine/metabolism , Enzyme Activation , Humans , Inflammation/chemically induced , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Linezolid , Macrophages/immunology , Macrophages/metabolism , Mice , Mitochondria/immunology , NLR Family, Pyrin Domain-Containing 3 Protein , Oxazolidinones/metabolism , Oxazolidinones/pharmacology , Potassium/metabolism , Reactive Oxygen Species/metabolism , Signal Transduction/immunology , Tumor Necrosis Factor-alpha/metabolism
8.
J Exp Med ; 207(7): 1359-67, 2010 Jul 05.
Article in English | MEDLINE | ID: mdl-20530203

ABSTRACT

A recessive mutation named Justy was found that abolishes B lymphopoiesis but does not impair other major aspects of hematopoiesis. Transplantation experiments showed that homozygosity for Justy prevented hematopoietic progenitors from generating B cells but did not affect the ability of bone marrow stroma to support B lymphopoiesis. In bone marrow from mutant mice, common lymphoid progenitors and pre-pro-B cells appeared normal, but cells at subsequent stages of B lymphopoiesis were dramatically reduced in number. Under culture conditions that promoted B lymphopoiesis, mutant pre-pro-B cells remained alive and began expressing the B cell marker CD19 but failed to proliferate. In contrast, these cells were able to generate myeloid or T/NK precursors. Genetic and molecular analysis demonstrated that Justy is a point mutation within the Gon4-like (Gon4l) gene, which encodes a protein with homology to transcriptional regulators. This mutation was found to disrupt Gon4l pre-mRNA splicing and dramatically reduce expression of wild-type Gon4l RNA and protein. Consistent with a role for Gon4l in transcriptional regulation, the levels of RNA encoding C/EBPalpha and PU.1 were abnormally high in mutant B cell progenitors. Our findings indicate that the Gon4l protein is required for B lymphopoiesis and may function to regulate gene expression during this process.


Subject(s)
B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Lymphopoiesis/genetics , Mutation/genetics , Nuclear Proteins/genetics , Transcription Factors/genetics , Animals , Base Sequence , Co-Repressor Proteins/genetics , Co-Repressor Proteins/metabolism , DNA-Binding Proteins , Gene Expression Regulation , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Male , Mice , Molecular Sequence Data , Nuclear Proteins/metabolism , Precursor Cells, B-Lymphoid/cytology , Precursor Cells, B-Lymphoid/metabolism , Protein Biosynthesis , RNA Splicing/genetics , Sequence Homology, Amino Acid , Transcription Factors/metabolism , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...